Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 2/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | ZDHHC20 | Q5W0Z9 | 2/20 | 0.37 |
| ▸ | ZDHHC2 | Q9UIJ5 | 2/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | HMGCR | P04035 | 2/20 | 0.36 |
| ▸ | PTPN7 | P35236 | 3/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bicarbonate SCHEMBL5539918 | 0.84 | HSD17B10 (0.50) | CYP1A2CYP2D6MAPTCYP2C9CYP2C19 | |
| Propiolic Acid SCHEMBL17554261 | 0.80 | HSD17B10 (0.46) | CYP1A2CYP2D6MAPTCYP2C9CYP2C19 | |
| Acrylic Acid SCHEMBL27822868 | 0.80 | — | — | |
| Hexane SCHEMBL1603152 | 0.79 | LMNA (0.59) | HSD17B10LMNAHPGDTSHRZDHHC20 | |
| Hexane SCHEMBL29985034 | 0.79 | LMNA (0.59) | HSD17B10LMNAHPGDTSHRZDHHC20 | |
| Acrylic Acid SCHEMBL29743129 | 0.79 | LMNA (0.59) | HSD17B10LMNAHPGDTSHRZDHHC20 | |
| Acrylic Acid SCHEMBL27900662 | 0.79 | TSHR (0.58) | LMNAHPGDTSHRZDHHC20ZDHHC2 | |
| Bicarbonate SCHEMBL29452854 | 0.78 | MAPT (0.54) | CYP1A2CYP2D6MAPTCYP2C9CYP2C19 | |
| Decane SCHEMBL5189736 | 0.77 | ZDHHC20 (0.56) | HSD17B10LMNAHPGDTSHRZDHHC20 | |
| Decane SCHEMBL8469924 | 0.77 | ZDHHC20 (0.56) | HSD17B10LMNAHPGDTSHRZDHHC20 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3810619-B1 | TETRA-NUCLEAR NEUTRAL COPPER (I) COMPLEXES | CLARIANT INT LTD (CH) | 2023-04-26 | — | — | EP | disclosed |
| US-20210253611-A1 | TETRA-NUCLEAR NEUTRAL COPPER (I) COMPLEXES WITH DIARYLPHOSPHINE LIGANDS | CLARIANT INTERNATIONAL LTD (CH) | 2021-08-19 | — | — | US | disclosed |
| US-20210159432-A1 | TETRA-NUCLEAR NEUTRAL COPPER (I) COMPLEXES | CLARIANT INTERNATIONAL LTD (CH) | 2021-05-27 | — | — | US | disclosed |
| EP-3810620-A1 | TETRA-NUCLEAR NEUTRAL COPPER (I) COMPLEXES WITH DIARYLPHOSPHINE LIGANDS | Clariant International Ltd (CH) | 2021-04-28 | — | — | EP | disclosed |
| EP-3810619-A1 | TETRA-NUCLEAR NEUTRAL COPPER (I) COMPLEXES | Clariant International Ltd (CH) | 2021-04-28 | — | — | EP | disclosed |
| CN-112601755-A | Tetranuclear neutral copper (I) complexes | 科莱恩国际有限公司 | 2021-04-02 | — | — | CN | disclosed |
| CN-112585148-A | Tetranuclear neutral copper (I) complexes with diarylphosphine ligands | 科莱恩国际有限公司 | 2021-03-30 | — | — | CN | disclosed |
| WO-2019243583-A1 | TETRA-NUCLEAR NEUTRAL COPPER (I) COMPLEXES | CLARIANT PLASTICS & COATINGS LTD (CH) | 2019-12-26 | — | — | WO | disclosed |
| WO-2019243581-A1 | TETRA-NUCLEAR NEUTRAL COPPER (I) COMPLEXES WITH DIARYLPHOSPHINE LIGANDS | CLARIANT PLASTICS & COATINGS LTD (CH) | 2019-12-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210253611-A1 | TETRA-NUCLEAR NEUTRAL COPPER (I) COMPLEXES WITH DIARYLPHOSPHINE LIGANDS | NPSR1, TACR1, HRH3 | CYP1A2 816/4885CYP2D6 2530/4885MAPT 3661/4885 |
| US-20210159432-A1 | TETRA-NUCLEAR NEUTRAL COPPER (I) COMPLEXES | NPY1R, TAAR1, CHRNA1 | CYP1A2 1958/4885CYP2D6 3320/4885MAPT 1650/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.